Details for Patent: 9,597,289

Which drugs does patent 9,597,289 protect, and when does it expire?

Patent 9,597,289 protects FLOLIPID and is included in one NDA.

This patent has twelve patent family members in twelve countries.

Summary for Patent: 9,597,289

Title:	Liquid oral simvastatin compositions
Abstract:	A suspension which is suitable for oral administration, comprising simvastatin, at least one suspending agent, and at least one preservative, wherein at least 90 wt % of the particles of simvastatin are less than 100 .mu.m in diameter. The present invention also includes uses of the suspension and methods of making the suspension.
Inventor(s):	Driver; Phillip (Keighley, GB)
Assignee:	ROSEMONT PHARMACEUTICALS LTD. (Leeds, GB)
Application Number:	12/298,451
Patent Claim Types: see list of patent claims	Compound; Dosage form;

Drugs Protected by US Patent 9,597,289

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Salerno Pharms	FLOLIPID	simvastatin	SUSPENSION;ORAL	206679-001	Apr 21, 2016		RX	Yes	No			Y
Salerno Pharms	FLOLIPID	simvastatin	SUSPENSION;ORAL	206679-002	Apr 21, 2016		RX	Yes	Yes			Y

Foreign Priority and PCT Information for Patent: 9,597,289

PCT Information
PCT Filed	April 26, 2007	PCT Application Number:	PCT/GB2007/001552
PCT Publication Date:	November 08, 2007	PCT Publication Number:	WO2007/125339

International Family Members for US Patent 9,597,289

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	E552825
Australia	2007245410
China	101431982
Cyprus	1112917